Soolantra

Soolantra (ivermectin 1% cream) is a prescription topical treatment for inflammatory lesions of rosacea, manufactured by Galderma. It is not a telehealth platform itself but surfaces organically in AI-generated answers about online dermatology, where WellRank currently places it at rank 12 in the Online Dermatology category with 8% AI-answer visibility.

Soolantra is a branded prescription medication developed and marketed by Galderma, a global dermatology-focused pharmaceutical company. The product is not a service or platform but a topical cream that patients access through in-person or telehealth dermatology encounters and then fill at a pharmacy. Galderma operates on a traditional pharmaceutical business model, meaning revenue comes from prescriptions dispensed rather than direct-to-consumer subscriptions.

• Ivermectin 1% topical cream as the active pharmaceutical ingredient
• Once-daily application approved for inflammatory lesions of rosacea
• Antiparasitic and anti-inflammatory mechanism targeting Demodex mites implicated in rosacea
• Prescription-only formulation requiring a licensed clinician visit, including telehealth visits
• Available through major retail and specialty pharmacies with manufacturer savings programs

Soolantra is prescribed for adults with rosacea, particularly those experiencing persistent inflammatory papules and pustules. It is approved and commercially available in the United States and several other markets. Patients are typically adults who have not achieved adequate control with other topical rosacea therapies.

• An adult with moderate-to-severe rosacea who has tried over-the-counter options without success and is seeking a clinician-prescribed solution.
• A telehealth dermatology patient who receives an online diagnosis and wants a once-daily prescription cream shipped to their local pharmacy.
• A primary-care or dermatology provider evaluating topical prescription options for a patient presenting with inflammatory rosacea lesions.
• A cost-conscious patient using platforms like GoodRx Care to find the most affordable path to a Soolantra prescription.

Soolantra is a product of Galderma, a privately held global dermatology company; specific revenue figures attributable to Soolantra alone are not publicly disclosed.

Galderma has broadly expanded its rosacea portfolio and digital patient-support resources over recent years, and Soolantra continues to be included in clinical treatment guidelines for rosacea. The brand has become increasingly visible in telehealth contexts as online dermatology platforms routinely prescribe topical rosacea treatments. No specific recent product reformulations or major label changes are widely reported.

WellRank's current corpus records one AI mention of Soolantra, which is positive in tone, with no neutral or cautious mentions logged to date. Broader patient and clinician commentary online generally reflects appreciation for its tolerability profile and targeted mechanism, though individual responses to rosacea treatments vary and some patients note cost as a consideration.

Soolantra is a prescription medication and its retail price varies by pharmacy, insurance coverage, and any applicable manufacturer savings card. Exact out-of-pocket figures are not published in a stable way; patients are typically advised to check with their pharmacy or use a savings program, as costs can differ substantially depending on insurance status.